| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.043 | 0.7 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.023 | 0.7 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.7 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.021 | 0.7 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.052 | 0.7 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |